MEET THE TEAM
Bharat Biotech’s India-made COVID-19 vaccine Covaxin has been asked to go the Biologics Licence Application (BLA) route with additional data, nixing hopes of Emergency Use Authorisation.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Post a comment